United States · FDA National Drug Code directory
Bupivacaine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70069-752_2b24af95-6f20-4945-bf8c-742f1d6f2721
- Product NDC
- 70069-752
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Bupivacaine hydrochloride
- Labeler
- Somerset Therapeutics, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20231127
- Source listing expiry
- 20261231
Source-listed ingredients
- BUPIVACAINE HYDROCHLORIDE — 2.5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (70069-752-01) / 50 mL in 1 VIAL · 70069-752-01
- 10 VIAL in 1 CARTON (70069-752-10) / 50 mL in 1 VIAL · 70069-752-10
- 25 VIAL in 1 CARTON (70069-752-25) / 50 mL in 1 VIAL · 70069-752-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →